Their trainee days are behind them, but they’re still too young to be considered senior scientists.

For women who take hydroxychloroquine (HCQ) to control rheumatic disease, research has shown that it’s best for mother and baby to continue the medicine during pregnancy. But should the dose be maintained, decreased, or increased? Stephen Balevic, MD, assistant professor of pediatrics and medicine (Rheumatology and Immunology), set out to investigate this question using data from the Duke Autoimmunity in Pregnancy registry. 

Subscribe to BalevicStephen